Ascentage Pharma (ADR) (AAPG)
Develops and commercializes hematology therapies in China and global clinical trials.
$15.51
vs last close−0.36 (−2.27%)
Something off on this page? Send us feedback.
EPSReportedEstimate
Dec '23Jun '24Aug '24Mar '25Aug '25Mar '26Aug '26Aug '26
Reported−$1.02$0.30$0.31−$1.00−$0.96−$0.65−$1.30−$1.28
Estimate———$0.02—−$0.83−$0.22$0.02
Surprise———−6,134.6%—+21.7%−491.0%−7,840.4%
RevenueReportedEstimate
Dec '23Jun '24Aug '24Mar '25Aug '25Mar '26Aug '26Aug '26
Reported$11.2M$113.4M$115.4M$21.5M$32.6M$49.5M$44.9M$44.0M
Estimate—————$44.4M$53.6M$24.1M
Surprise—————+11.5%−16.4%+83.1%
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$1.97 | — | — |
| Sep 2028 | −$2.00 | — | — |
| Jun 2028 | −$1.97 | — | — |
| Mar 2028 | −$3.59 | — | — |
| Dec 2027 | −$2.91 | — | — |
| Sep 2027 | −$5.74 | — | — |
| Jun 2027 | −$5.63 | — | — |
| Mar 2027 | $0.11 | — | — |
| Mar 2027 | −$0.33 | — | — |
| Sep 2026 | $0.11 | — | — |
| Aug 2026 | $0.02 | −$1.28 | −7,840.4% |
| Aug 2026 | −$0.22 | −$1.30 | −491.0% |
| Mar 2026 | −$0.83 | −$0.65 | +21.7% |
| Aug 2025 | — | −$0.96 | — |
| Mar 2025 | |||
| Aug 2024 | |||
| Jun 2024 | |||
| Dec 2023 | |||
| Aug 2023 | |||
| Jun 2023 | |||
| Dec 2022 | |||
| Aug 2022 | |||
| Jun 2022 | |||
| Dec 2021 | |||
| Aug 2021 | |||
| Jun 2021 | |||
| Dec 2020 | |||
| Jun 2020 | |||
| Aug 2020 | |||
| Dec 2019 | |||
| Jun 2019 | |||
| Dec 2018 | |||
| Jun 2018 | |||
| Dec 2017 | |||
| Jun 2017 | |||
| Dec 2016 | |||
| Jun 2016 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$1.97 | — | — | $458.7M | — | — | — |
| Sep 2028 | −$2.00 | — | — | $458.7M | — | — | — |
| Jun 2028 | −$1.97 | — | — | $393.0M | — | — | — |
| Mar 2028 | −$3.59 | — | — | $425.2M | — | — | — |
| Dec 2027 | −$2.91 | — | — | $356.5M | — | — | — |
| Sep 2027 | −$5.74 | — | — | $310.5M | — | — | — |
| Jun 2027 | −$5.63 | — | — | $310.5M | — | — | — |
| Mar 2027 | $0.11 | — | — | $512.0M | — | — | — |
| Mar 31, 2027 | −$0.33 | — | — | $48.6M | — | — | — |
| Sep 2026 | $0.11 | — | — | $431.7M | — | — | — |
| Aug 20, 2026 | $0.02 | −$1.28 | −7,840.4% | $24.1M | $44.0M | +83.1% | −0.9% |
| Aug 18, 2026 | −$0.22 | −$1.30 | −491.0% | $53.6M | $44.9M | −16.4% | 0.0% |
| Mar 24, 2026 | −$0.83 | −$0.65 | +21.7% | $44.4M | $49.5M | +11.5% | +0.3% |
| Aug 20, 2025 | — | −$0.96 | — | — | $32.6M | — | +1.7% |
| Mar 27, 2025 | |||||||
| Aug 22, 2024 | |||||||
| Jun 30, 2024 | |||||||
| Dec 31, 2023 | |||||||
| Aug 21, 2023 | |||||||
| Jun 30, 2023 | |||||||
| Dec 31, 2022 | |||||||
| Aug 26, 2022 | |||||||
| Jun 30, 2022 | |||||||
| Dec 31, 2021 | |||||||
| Aug 24, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Aug 18, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Jun 30, 2016 |